Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Probioseutics is a biotechnology company focused on the research, development, and commercialization of advanced probiotic formulations and microbial therapies. Founded by Dr. Khem Shahani, a pioneer in probiotic research, the company leverages decades of scientific expertise to produce high-quality strains such as Lactobacillus acidophilus DDS-1. Their products are designed to support gastrointestinal health and immune function through evidence-based microbial interventions. Probioseutics serves both the consumer nutraceutical market and clinical research applications, emphasizing strain stability and documented health benefits.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Probioseuticals.